DIBS
1stdibs.Com, Inc.
DIBS has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
DIBS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Unavailable |
DIBS's revenue and cash flow are currently stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DIBS PE Valuation
DIBS has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
DIBS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect DIBS's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DIBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.15 | +$0.35 |
| Q2 2026 | -$0.21 | +$0.34 |
| Q1 2026 | -$0.30 | +$0.25 |
| Q4 2025 | -$0.38 | +$0.11 |
| Q3 2025 | -$0.50 | -$0.08 |
| Q2 2025 | -$0.55 | -$0.20 |
| Q1 2025 | -$0.55 | -$0.11 |
| Q4 2024 | -$0.49 | +$0.08 |
DIBS is still losing money, but far less than before: $0.15 per share over the past year, against $0.83 at its worst in mid-2023.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
DIBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.1M | +5.1% |
| Q2 2026 | $23.3M | +5.3% |
| Q1 2026 | $22.4M | -0.7% |
| Q4 2025 | $23M | +0.9% |
| Q3 2025 | $22M | +3.7% |
| Q2 2025 | $22.1M | -0.4% |
| Q1 2025 | $22.5M | +2.2% |
| Q4 2024 | $22.8M | +8.8% |
DIBS's revenue grew through 2022 and has held roughly level since: $23M last quarter, up 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.8% | +12 points |
| Q2 2026 | -8.8% | +17 points |
| Q1 2026 | -15% | +13 points |
| Q4 2025 | -10% | +21 points |
| Q3 2025 | -21% | +14 points |
| Q2 2025 | -26% | +3.4 points |
| Q1 2025 | -28% | -3.5 points |
| Q4 2024 | -31% | -5.9 points |
DIBS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over DIBS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
DIBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +$4.4M |
| Q2 2026 | -$5.1M | +$121K |
| Q1 2026 | $827K | +$970K |
| Q4 2025 | $3.6M | +30% |
| Q3 2025 | -$1.5M | -$1.4M |
| Q2 2025 | -$5.2M | -$2.2M |
| Q1 2025 | -$143K | +$3.1M |
| Q4 2024 | $2.8M | +$4.9M |
DIBS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
DIBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -727K shares |
| 1 year | -7.2% | -2.6M shares |
| 3 years | -16% | -6.2M shares |
| 5 years | +103% | +17.1M shares |
| Available history | +9.9% | +3M shares |
DIBS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $11.6M |
| Q1 2026 | $9.1M |
| Q4 2025 | $1.6M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $1.8M |
| Q4 2024 | $5M |
DIBS spent $22M buying back its own shares over the past year, about three times what it spent the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
DIBS Net Leverage
DIBS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DIBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.5 | Neutral |
| Stochastic | 87.5 | Overbought |
DIBS's weekly RSI is 63 (neutral) and its Stochastic is 88 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DIBS PE vs Consumer Cyclical Sector
DIBS has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
DIBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.67 | 25% above |
| 20 week MA | $4.61 | 26% above |
| 50 week MA | $5.00 | 17% above |
| 100 week MA | $4.08 | 43% above |
| 200 week MA | $4.30 | 36% above |
DIBS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
DIBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.1 | $12.8 | -47% |
| 2022 | $12.8 | $5.00 | -61% |
| 2023 | $5.00 | $4.68 | -6.4% |
| 2024 | $4.68 | $3.69 | -21% |
| 2025 | $3.69 | $5.91 | +60% |
| 2026 YTD | $5.91 | $5.83 | -1.4% |
DIBS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.